相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A systematic review and meta-analysis of the prognostic value of radiomics based models in non-small cell lung cancer treated with curative radiotherapy
Gargi Kothari et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial
Corinne Faivre-Finn et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
The Blessings of Multiple Causes
Yixin Wang et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2019)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer
M. Jamal-Hanjani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Decision Making in Lung Cancer - How Applicable are the Guidelines?
S. K. Vinod
CLINICAL ONCOLOGY (2015)
Measurement bias and effect restoration in causal inference
Manabu Kuroki et al.
BIOMETRIKA (2014)
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
C. M. Booth et al.
BRITISH JOURNAL OF CANCER (2014)
Bias attenuation results for nondifferentially mismeasured ordinal and coarsened confounders
Elizabeth L. Ogburn et al.
BIOMETRIKA (2013)
Treatment of Stage III Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Nithya Ramnath et al.
CHEST (2013)
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer
Anne Auperin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values
Ian R. White et al.
STATISTICS IN MEDICINE (2010)
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies
Erik von Elm et al.
ANNALS OF INTERNAL MEDICINE (2007)
Participation of patients 65 years of age or older in cancer clinical trials
JH Lewis et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Greedy function approximation: A gradient boosting machine
JH Friedman
ANNALS OF STATISTICS (2001)